Benzimidazole C-2 heterocycles as kinase inhibitors

Details Benzimidazole C-2 heterocycles as kinase inhibitors Benzimidazole C-2 heterocycles as kinase inhibitors

2007-12-25

2007-12-25

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S114000, C544S122000, C544S123000, C544S131000, C544S139000

Reexamination Certificate

active

10894938

ABSTRACT:
Benzimidazole derivatives having the general formula Iare provided. These compounds are useful as tyrosine kinase inhibitors, especially for the treatment of cancer.

REFERENCES:
patent: 5650415 (1997-07-01), Tang et al.
patent: 6465484 (2002-10-01), Bilodeau et al.
patent: 0 385 850 (2000-09-01), None
patent: 63-230687 (1988-09-01), None
patent: WO 99/60023 (1999-11-01), None
patent: WO 00/02871 (2000-01-01), None
patent: WO 00/08202 (2000-02-01), None
patent: WO 00/12089 (2000-03-01), None
patent: WO 00/17203 (2000-03-01), None
patent: WO 00/20023 (2000-04-01), None
patent: WO 00/23469 (2000-04-01), None
patent: WO 00/35455 (2000-06-01), None
patent: WO 00/53605 (2000-09-01), None
patent: WO 01/17995 (2001-03-01), None
patent: WO 01/60816 (2001-08-01), None
patent: WO 01/72751 (2001-10-01), None
patent: WO 02/079192 (2002-10-01), None
Parrizas, et al. (1997) Endocrinology 138: 1427-1433.
Blum, et al. (2000) Biochemistry 39:15705-15712.
Gungor, et al. (1992) J. Med. Chem. 35:4455-4463.
Sahal, et al. (1988) Archives of Biochemistry and Biophysics 260:416-426.
U.S. Appl. No. 10/263,448, filed Oct. 2, 2002, Wittman et al.
U.S. Appl. No. 10/674,098, filed Sep. 29, 2003, Velaparthi et al.
Chimirri et al., Heterocycles, vol. 53, No. 3, pp. 613-620, 2000.
Nawwar et al., Chemical Abstract No. 164052r, vol. 120, No. 13, Mar. 28, 1994.
Pednekar et al., Chemical Abstracts No. 182731b, vol. 96, No. 22, May 31, 1982.

Affiliated with

Also associated with

Rating

Benzimidazole C-2 heterocycles as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole C-2 heterocycles as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole C-2 heterocycles as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3870937